Advanced search
Publication Cover
Cancer Investigation Volume 20, 2002 - Issue 7-8
Submit an article Journal homepage
39
Views
3
CrossRef citations to date
0
Altmetric
Original

CI-980 for the Treatment of Recurrent or Progressive Malignant Gliomas: National Central Nervous System Consortium Phase I–II Evaluation of CI-980

Lara J. Kunschner Department of Neuro-Oncology, M. D. Anderson Cancer Center, University of Texas, Box 431, 1515 Holcombe Boulevard, Houston, TX, 77030, U.S.A.; Department of Biomathematics, M. D. Anderson Cancer Center, University of Texas, Box 431, 1515 Holcombe Boulevard, Houston, TX, 77030, U.S.A.
,
Howard Fine Allegheny Neurological Associates, Pittsburgh, Pennsylvania, U.S.A.; Dana Farber Cancer Institute, Boston, Massachusetts, U.S.A.
,
Kenneth Hess National Cancer Institute, Bethesda, Maryland, U.S.A.
,
Kurt Jaeckle Department of Neuro-Oncology, M. D. Anderson Cancer Center, University of Texas, Box 431, 1515 Holcombe Boulevard, Houston, TX, 77030, U.S.A.; Mayo Clinic, Jacksonville, Florida, U.S.A.
,
Athanassios P. Kyritsis Department of Neuro-Oncology, M. D. Anderson Cancer Center, University of Texas, Box 431, 1515 Holcombe Boulevard, Houston, TX, 77030, U.S.A.; Ioannina University, Ioannina, Greece
&
W. K. Alfred Yung Department of Neuro-Oncology, M. D. Anderson Cancer Center, University of Texas, Box 431, 1515 Holcombe Boulevard, Houston, TX, 77030, U.S.A.
Pages 948-954 | Published online: 27 Nov 2002

REFERENCES

  • Levin V.A., Prados M.R., Wara W.M., Davis R.L., Gutin P.H., Phillips T.L., Lamborn K., Wilson C.B. Radiation Therapy and Bromodeoxyuridine Chemotherapy Followed by Procarbazine, Lomustine, and Vincristine for the Treatment of Anaplastic Gliomas. Int. J. Radiat. Oncol. Biol. Phys. 1995; 32: 75–83
  • Prados M.D., Scott C., Sandler H., Buckner J.C., Phillips T., Schultz C., Urtasun R., Davis R., Gutin P., Cascino T.L., Greenberg H.S., Curran W.J., Jr. A Phase 3 Randomized Study of Radiotherapy Plus Procarbazine, CCNU, and Vincristine (PCV) with or without BUdR for the Treatment of Anaplastic Astrocytoma: A Preliminary Report of RTOG 9404 [see Comments]. Int. J. Radiat. Oncol. Biol. Phys. 1999; 45: 1109–1115
  • Wheeler G.P., Bowdon B.J., Temple C., Jr., Adamson D.J., Webster J. Biological Effects and Structure–Activity Relationships of 1,2-Dihydropyrido[3,4-b]pyrazines. Cancer Res. 1983; 43: 3567–3575
  • de Ines C., Leynadier D., Barasoain I., Peyrot V., Garcia P., Briand C., Rener G.A., Temple C., Jr. Inhibition of Microtubules and Cell Cycle Arrest by a New 1-Deaza-7,8-dihydropteridine Antitumor Drug, CI 980, and by Its Chiral Isomer, NSC 613863. Cancer Res. 1994; 54: 75–84
  • Waud W.R., Leopold W.R., Elliott W.L., Dykes D.J., Laster W.R., Jr., Temple C.G., Jr., Harrison S.D., Jr., Griswold D.P., Jr. Antitumor Activity of Ethyl 5-Amino-1,2-dihydro-2-methyl-3-phenyl-pyrido [3,4-b]pyrazin-7-ylcarbamate, 2-Hydroxyethanesulfonate, Hydrate (NSC 370147) Against Selected Tumor Systems in Culture and in Mice. Cancer Res. 1990; 50: 3239–3244
  • Garcia P., Braguer D., Carles G., Briand C. Simultaneous Combination of Microtubule Depolymerizing and Stabilizing Agents Acts at Low Doses. Anti-Cancer Drugs 1995; 6: 533–544
  • Sklarin N.T., Lathia C.D., Benson L., Grove W.R., Thomas S., Roca J., Einzig A.I., Wiernik P.H. A Phase I Trial and Pharmacokinetic Evaluation of CI-980 in Patients with Advanced Solid Tumors. Investig. New Drugs 1997; 15: 235–246
  • Rowinsky E.K., Long G.S., Noe D.A., Grochow L.B., Bowling M.K., Sartorius S.E., Donehower R.C. Phase I and Pharmacological Study of CI-980, a Novel Synthetic Antimicrotubule Agent. Clin. Cancer Res. 1997; 3: 401–407
  • Gutheil J., Echo D.V., Egorin M., Panitch H., Swallow L., O'Hara S., Kearns C. Phase I Study of CI-980 in Patients with Refractory Malignancies. Proc. Am. Assoc. Cancer Res. 1996; 37: 164
  • Bernstein M.L., Baruchel S., Devine S., Markoglou N., Wainer I.W., Williams M., Blaney S., Moghrabi A., Winick N., Vietti T. Phase I and Pharmacokinetic Study of CI-980 in Recurrent Pediatric Solid Tumor Cases: A Pediatric Oncology Group Study. J. Pediatr. Hematol./Oncol. 1999; 21: 494–500
  • Pazdur R., Meyers C., Diaz-Canton E., Abbruzzese J.L., Patt Y., Grove W., Ajani J. Phase II Trial of Intravenous CI-980 (NSC 370147) in Patients with Metastatic Colorectal Carcinoma. Model for Prospective Evaluation of Neurotoxicity. Am. J. Clin. Oncol. 1997; 20: 573–576
  • Kudelka A.P., Hasenburg A., Verschraegen C.F., Edwards C.L., Meyers C.A., Varma D., Freedman R.S., Forman A., Conrad C.A., Grove W., Grothey A., Kavanagh J.J. Phase II Study of i.v. CI-980 in Patients with Advanced Platinum Refractory Epithelial Ovarian Carcinoma. Anti-Cancer Drugs 1998; 9: 405–409
  • Meyers C.A., Kudelka A.P., Conrad C.A., Gelke C.K., Grove W., Pazdur R. Neurotoxicity of CI-980, a Novel Mitotic Inhibitor. Clin. Cancer Res. 1997; 3: 419–422
  • Simon R. Optimal Two-Stage Designs for Phase II Clinical Trials. Control. Clin. Trials 1989; 10: 1–10
  • Hook K.E., Przybranowski S.A., Leopold W.R. Cellular Transport of CI-980. Investig. New Drugs 1996; 14: 341–347
  • Kim S.N., Watkins J.R., Gough A.W. Intravenous Toxicity of CI-980, a Mitotic Inhibitor, in Mice and Rats. Fed. Am. Soc. Exp. Biol. 1991; 5: 485

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.